Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
SCHEDULE OF OTHER CURRENT ASSETS

Other current assets consisted of the following as of September 30, 2021 and December 31, 2020:

 SCHEDULE OF OTHER CURRENT ASSETS

    September 30, 2021     December 31, 2020  
    (unaudited)        
Lab supply inventory   $ 2,271     $ 2,052  
Prepaid expenses     734       625  
Other     130       45  
Total other current assets   $ 3,135     $ 2,722  
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE

 SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE

                         
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2021     2020     2021     2020  
    (unaudited)     (unaudited)  
Basic weighted average number of common shares     4,165       4,038       4,119       4,025  
Potential dilutive effect of stock-based awards     -       -       -       -  
Diluted weighted average number of common shares     4,165       4,038       4,119       4,025  
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

 SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2021     2020     2021     2020  
    (unaudited)     (unaudited)  
Options     684       878       684       878  
Restricted stock and restricted stock units (RSUs)     366       28       366       28  
Warrants     1,405       1,405       1,405       1,405  
      2,455       2,311       2,455       2,311